ID 1507.2 AC CVCL_1Y71 SY S1507-2 DR Wikidata; Q54581966 RX PubMed=21695156; RX PubMed=23437333; RX PubMed=28556483; ST Source(s): PubMed=28556483 ST Amelogenin: X ST CSF1PO: 11,12 ST D13S317: 9 ST D16S539: 9,10 ST D18S51: 12 ST D19S433: 13,15 ST D21S11: 28 ST D2S1338: 18,23 ST D3S1358: 17 ST D5S818: 11,12 ST D7S820: 12 ST D8S1179: 14 ST FGA: 24 ST TH01: 9.3 ST TPOX: 11,12 ST vWA: 15 DI NCIt; C3798; Malignant peripheral nerve sheath tumor DI NCIt; C3273; Neurofibromatosis type 1 DI ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor DI ORDO; Orphanet_636; Neurofibromatosis type 1 OX NCBI_TaxID=9606; ! Homo sapiens (Human) CA Cancer cell line DT Created: 22-09-15; Last updated: 21-03-23; Version: 5 // RX PubMed=28556483; DOI=10.1002/1878-0261.12086; PMCID=PMC5579334; RA Kolberg, Matthias RA Bruun, Jarle RA Murumagi, Astrid RA Mpindi, John Patrick RA Bergsland, Christian H. RA Holand, Maren RA Eilertsen, Ina A. RA Danielsen, Stine A. RA Kallioniemi, Olli-Pekka RA Lothe, Ragnhild Adelheid RT "Drug sensitivity and resistance testing identifies PLK1 inhibitors RT and gemcitabine as potent drugs for malignant peripheral nerve sheath RT tumors."; RL Mol. Oncol. 11:1156-1171(2017). // RX PubMed=23437333; DOI=10.1371/journal.pone.0057152; PMCID=PMC3578816; RA Reuss, David E. RA Mucha, Jana RA Hagenlocher, Christian RA Ehemann, Volker RA Kluwe, Lan RA Mautner, Victor-Felix RA von Deimling, Andreas RT "Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL RT is augmented by loss of NF1 through modulation of MYC/MAD and is RT potentiated by curcumin through induction of ROS."; RL PLoS ONE 8:e57152.1-e57152.10(2013). // RX PubMed=21695156; DOI=10.1371/journal.pone.0021099; PMCID=PMC3113907; RA Spyra, Melanie RA Kluwe, Lan RA Hagel, Christian RA Nguyen, Rosa RA Panse, Jens RA Kurtz, Andreas RA Mautner, Victor-Felix RA Rabkin, Samuel David RA Demestre, Maria RT "Cancer stem cell-like cells derived from malignant peripheral nerve RT sheath tumors."; RL PLoS ONE 6:e21099.1-e21099.9(2011). //